Rapid resolution of erythrodermic atopic dermatitis with upadacitinib: A case report

被引：0

作者：

Saad, Mysa ^{[1
]}

Guirguis, Marina ^{[1
]}

Hamm, Camille ^{[2
]}

Bose, Reetesh ^{[1
,2
]}

机构：

[1] Univ Ottawa, Fac Med, Roger Guindon Hall, Ottawa, ON, Canada

[2] Ottawa Hosp, Div Dermatol, 737 Parkdale Ave, Ottawa, ON K1Y 4M9, Canada

来源：

SAGE OPEN MEDICAL CASE REPORTS | 2024年 / 12卷

关键词：

Erythrodermic atopic dermatitis; upadacitinib; JAK inhibitor; dupilumab; prednisone; DUPILUMAB; SAFETY;

D O I：

10.1177/2050313X241260497

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atopic dermatitis is a chronic inflammatory skin disease that may progress to erythroderma in severe cases. Biologic agents such as dupilumab have recently become the mainstay of systemic treatment for moderate-to-severe cases, yet many patients remain refractory to therapy. Here, we present a case of erythrodermic atopic dermatitis, resistant to prednisone and dupilumab, with remarkably rapid achievement of remission following treatment with upadacitinib, an oral selective Janus kinase 1 inhibitor.

引用

页数：3

共 50 条

[31] Rapid improvement in pruritus in atopic dermatitis patients treated with upadacitinib: a real-life experience
Napolitano, M.
Fabbrocini, G.
Genco, L.
Martora, F.
Potestio, L.
Patruno, C.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (09) : 1497 - 1498
[32] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF UPADACITINIB IN CHILDREN WITH ATOPIC DERMATITIS
Qian, Y.
Raymundo, E.
Hao, S.
Unnebrink, K.
Liu, J.
Teixeira, H.
Chu, A.
Paller, A.
Liu, W.
Mohamed, M.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S78 - S78
[33] Molluscum contagiosum under treatment with upadacitinib for atopic dermatitis
Bertoli, Cristina
Longo, Caterina
Di Lernia, Vito
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
[34] Oral Upadacitinib Beats Subcutaneous Dupilumab for Atopic Dermatitis
Slomski, Anita
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (13): : 1246 - 1246
[35] Insulin glargine/insulin lisproDiffuse erythrodermic eczematous dermatitis: case report
Reactions Weekly, 2014, 1498 (1) : 17 - 17
[36] Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib
Grieco, Teresa
Caviglia, Martina
Cusano, Giuseppina
Sernicola, Alvise
Chello, Camilla
Del Duca, Ester
Cantisani, Carmen
Taliano, Alberto
Sini, Nicolo
Ianiro, Gianluca
Pellacani, Giovanni
MEDICINA-LITHUANIA, 2023, 59 (03):
[37] Metabolic effects of upadacitinib in patients with psoriasis and atopic dermatitis
Posada, Marielos I. Posada
Alora, Maria Beatrice
Lima, Xinaida Taligare Vasconcelos
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (05)
[38] Atopic Dermatitis: Upadacitinib more effective than Dupilumab
Metzger, Leandra
AKTUELLE DERMATOLOGIE, 2021, 47 (12) : 521 - 521
[39] EtanerceptFirst report of atopic dermatitis in a child: case report
Reactions Weekly, 2004, 985 (1) : 9 - 9
[40] Retreatment with upadacitinib in atopic dermatitis: experience in clinical practice
Martinez-Fernandez, S.
Suh-Oh, H. J.
Batalla, A.
Couselo-Rodriguez, C.
Espasandin-Arias, M.
Florez, A.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)

← 1 2 3 4 5 →